Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones
| dc.contributor.author | Madikizela, Balungile | |
| dc.contributor.author | Eckhardt, Tamira | |
| dc.contributor.author | Goddard, Richard | |
| dc.contributor.author | Richter, Adrian | |
| dc.contributor.author | Lins, Anika | |
| dc.contributor.author | Lehmann, Christoph | |
| dc.contributor.author | Imming, Peter | |
| dc.contributor.author | Seidel, Rudiger W. | |
| dc.date.accessioned | 2022-05-24T09:21:53Z | |
| dc.date.available | 2022-05-24T09:21:53Z | |
| dc.date.issued | 2021-08 | |
| dc.description.abstract | 8-Nitro-1,3-benzothiazin-4-ones (BTZs), with BTZ043 and PBTZ169 as the most advanced compounds, represent a new class of potent antitubercular agents, which irreversibly inhibit decaprenylphosphoryl-β-D-ribose-2′-epimerase (DprE1), an enzyme crucial for cell wall synthesis in the pathogen Mycobacterium tuberculosis. Synthesis, structural characterization and in vitro testing against Mycobacterium aurum DSM 43999 and M. tuberculosis H37Rv of halogenated 2-(4-ethoxycarbonylpiperazin-1-yl)-1,3-benzothiazin-4-ones lacking a nitro group are reported. X-ray crystallography reveals that the structure of the BTZ scaffold can significantly deviate from planarity. In contrast to recent reports, the results of the present study indicate that further investigation of halogenated non-nitro BTZs for antitubercular activity is less than a promising approach. | en_US |
| dc.description.department | Paraclinical Sciences | en_US |
| dc.description.librarian | am2022 | en_US |
| dc.description.sponsorship | The TWAS-DFG Coorperation Visits Programme from the Deutsche Forschungsgemeinschaft and The World Academy of Sciences. Open Access funding enabled and organized by Projekt DEAL. | en_US |
| dc.description.uri | http://link.springer.com/journal/44 | en_US |
| dc.identifier.citation | Madikizela, B., Eckhardt, T., Goddard, R. et al. Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones Medicinal Chemistry Research 30, 1523–1533 (2021). https://doi.org/10.1007/s00044-021-02735-4. | en_US |
| dc.identifier.issn | 1054-2523 (print) | |
| dc.identifier.issn | 1554-8120 (online) | |
| dc.identifier.other | 10.1007/s00044-021-02735-4 | |
| dc.identifier.uri | https://repository.up.ac.za/handle/2263/85647 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.rights | © The Author(s) 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License. | en_US |
| dc.subject | Benzothiazinones | en_US |
| dc.subject | Antimycobacterial evaluation | en_US |
| dc.subject | In vitro activity | en_US |
| dc.subject | Synthesis | en_US |
| dc.subject | Crystal structure | en_US |
| dc.subject | Tuberculosis (TB) | en_US |
| dc.title | Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.75 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
